Clareo Health | Comparison of the Performance of an Optimized 3D EPI SWI Sequence and a Non-EPI QSM SWI Sequence in Detecting the Central Vein Sign in Patients With Multiple Sclerosis
Comparison of the Performance of an Optimized 3D EPI SWI Sequence and a Non-EPI QSM SWI Sequence in Detecting the Central Vein Sign in Patients With Multiple Sclerosis
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fondation Ophtalmologique Adolphe de Rothschild
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients over 18
With MS defined according to the McDonald's revised clinical or radiological spatial and temporal dissemination criteria, with onset of symptoms \<5 years
To benefit as part of care from an MRI with or without injection of gadolinium
Express consent to participate in the study
Affiliate or beneficiary of a social security scheme
You may not be if
Patient benefiting from a legal protection measure
